Literature DB >> 29502285

Evaluation of hollow fiber culture for large-scale production of mouse embryonic stem cell-derived hematopoietic stem cells.

Yu Nakano1, Shinya Iwanaga1, Hiroshi Mizumoto2, Toshihisa Kajiwara3.   

Abstract

Hematopoietic stem cells (HSCs) have the ability to differentiate into all types of blood cells and can be transplanted to treat blood disorders. However, it is difficult to obtain HSCs in large quantities because of the shortage of donors. Recent efforts have focused on acquiring HSCs by differentiation of pluripotent stem cells. As a conventional differentiation method of pluripotent stem cells, the formation of embryoid bodies (EBs) is often employed. However, the size of EBs is limited by depletion of oxygen and nutrients, which prevents them from being efficient for the production of HSCs. In this study, we developed a large-scale hematopoietic differentiation approach for mouse embryonic stem (ES) cells by applying a hollow fiber (HF)/organoid culture method. Cylindrical organoids, which had the potential for further spontaneous differentiation, were established inside of hollow fibers. Using this method, we improved the proliferation rate of mouse ES cells to produce an increased HSC population and achieved around a 40-fold higher production volume of HSCs in HF culture than in conventional EB culture. Therefore, the HF/organoid culture method may be a new mass culture method to acquire pluripotent stem cell-derived HSCs.

Entities:  

Keywords:  Hematopoietic differentiation; Hollow fiber; Pluripotent stem cell; Three-dimensional culture

Year:  2018        PMID: 29502285      PMCID: PMC6021284          DOI: 10.1007/s10616-018-0210-z

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  33 in total

1.  Mass transfer limitations in embryoid bodies during human embryonic stem cell differentiation.

Authors:  Allison P Van Winkle; Ian D Gates; Michael S Kallos
Journal:  Cells Tissues Organs       Date:  2012-01-12       Impact factor: 2.481

Review 2.  Hematopoietic stem cell: self-renewal versus differentiation.

Authors:  Jun Seita; Irving L Weissman
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Nov-Dec

Review 3.  Transplantation of hematopoietic stem cells from the peripheral blood.

Authors:  Jan Jansen; Susan Hanks; James M Thompson; Michael J Dugan; Luke P Akard
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

4.  Establishment in culture of pluripotential cells from mouse embryos.

Authors:  M J Evans; M H Kaufman
Journal:  Nature       Date:  1981-07-09       Impact factor: 49.962

Review 5.  Mesodermal and hematopoietic differentiation from ES and iPS cells.

Authors:  Tomoko Inoue-Yokoo; Kenzaburo Tani; Daisuke Sugiyama
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

6.  The microwell control of embryoid body size in order to regulate cardiac differentiation of human embryonic stem cells.

Authors:  Jeffrey C Mohr; Jianhua Zhang; Samira M Azarin; Andrew G Soerens; Juan J de Pablo; James A Thomson; Gary E Lyons; Sean P Palecek; Timothy J Kamp
Journal:  Biomaterials       Date:  2009-11-28       Impact factor: 12.479

7.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

8.  Insulin-like growth factor-binding protein 2 secreted by a tumorigenic cell line supports ex vivo expansion of mouse hematopoietic stem cells.

Authors:  Hoangdinh Huynh; Satoru Iizuka; Megan Kaba; Oktay Kirak; Junke Zheng; Harvey F Lodish; Cheng Cheng Zhang
Journal:  Stem Cells       Date:  2008-03-27       Impact factor: 6.277

9.  Hematopoietic commitment during embryonic stem cell differentiation in culture.

Authors:  G Keller; M Kennedy; T Papayannopoulou; M V Wiles
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

Review 10.  The HLA system: genetics, immunology, clinical testing, and clinical implications.

Authors:  Sung Yoon Choo
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.